Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PAR-6β Inhibitors

PAR-6β inhibitors are a class of chemical compounds that specifically target and inhibit the activity of partitioning defective 6 homolog beta (PAR-6β), a key component in the regulation of cell polarity and asymmetric cell division. PAR-6β is part of the Par polarity complex, which includes other proteins such as PAR-3 and aPKC (atypical protein kinase C), and plays a critical role in establishing and maintaining cell polarity. This complex is essential for a variety of cellular processes, including cell migration, the formation of tight junctions, and the spatial orientation of cells within tissues. By inhibiting PAR-6β, these compounds interfere with its ability to regulate the assembly and function of the Par complex, which in turn can disrupt cell polarity and the organization of cellular architecture.

The mechanism of PAR-6β inhibitors involves binding to the protein, preventing its interaction with other members of the Par complex or inhibiting its ability to participate in signal transduction pathways that control cell polarity. This inhibition can alter various cellular processes that rely on the proper orientation and spatial organization of cells, such as epithelial tissue formation, neural development, and the maintenance of cell junctions. PAR-6β inhibitors are valuable tools for studying how cell polarity is established and maintained, as well as how disruptions in this process can lead to changes in tissue organization and cellular behavior. By blocking the function of PAR-6β, researchers can explore the intricate molecular mechanisms that govern cell polarity and the formation of structured tissues, shedding light on the fundamental processes that control cellular organization and division.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound could demethylate DNA at the PAR-6β gene promoter, potentially leading to transcriptional repression and subsequent downregulation of PAR-6β expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A may cause hyperacetylation of histones at the PAR-6β locus, resulting in chromatin compaction and decreased accessibility for transcriptional machinery, thus reducing PAR-6β mRNA synthesis.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

By inhibiting the PI3K enzyme, LY 294002 could disrupt AKT signaling, leading to the downregulation of transcriptional activators or stabilization of repressors involved in PAR-6β gene expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin binds to mTOR, inhibiting its activity, which may lead to a decrease in the translation of transcriptional regulators of the PAR-6β gene, effectively decreasing PAR-6β protein synthesis.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin could reduce the transcriptional activity on the PAR-6β promoter by altering the activity of specific transcription factors, leading to decreased expression levels of PAR-6β.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol may attenuate the expression of PAR-6β by disrupting the function of transcriptional coactivators or enhancing the action of corepressors that bind to the PAR-6β gene promoter.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 could decrease PAR-6β expression by inhibiting JNK, which may be required for the phosphorylation of transcription factors that promote PAR-6β gene transcription.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 might prevent the activation of MEK1/2, leading to reduced ERK phosphorylation and activity, which could decrease the expression of PAR-6β by lowering transcriptional activation of its gene.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 can inhibit MEK, potentially resulting in reduced activation of downstream transcription factors and a consequent decrease in PAR-6β transcriptional initiation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 may inhibit p38 MAPK activity, leading to a reduction in the phosphorylation state of transcription factors that are crucial for the initiation of PAR-6β gene transcription.